fda warning bpc 157 unapproved drug marketing warning letter to Harry D. Bear, M.D., Ph.D. 2002-09-27 New FTC Warning Letters Issued

Key Takeaways Cagrilintide is a long-acting amylin analogue being studied for appetite regulation, satiety, body-weight reduction, and metabolic disease research

The Khavinson primate studies are most relevant here: Epitalon increased nighttime melatonin in old monkeys while having no effect on young ones

not for human or veterinary use Key Characteristics of BPC-157 (20mg) Supplied as a high-purity, lyophilized research peptide Defined amino acid sequence supports consistent and reproducible experimental outcomes Commonly used in cell-based and tissue-focused research models Higher total peptide content supports extended or multi-phase experimental workflows Stable under recommended storage conditions Compatible with standard laboratory peptide handling and reconstitution protocols Used in non-clinical research contexts to investigate biological responses linked to tissue organization, vascular behavior, and signaling pathways, including endpoints such as cell migration, barrier integrity markers, and extracellular-matrix-related readouts in preclinical models

Lastly, the package incorporates NAD+ and NAD+ Precursor Therapy